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Abstract  
 Cardiovascular diseases (CVD) can induce dysfunction in organ systems by attenuating normal blood flow. Gonadal steroids are vasoactive hormones, but their role in contributing to cardiovascular function remains controversial. We have demonstrated that gonadal steroids can relax coronary arteries by opening the large-conductance, calcium- and voltage-activated potassium (BKCa) channel in smooth muscle cells by increasing cyclic nucleotide levels; however, the signaling pathways involved remain to be elucidated. The purpose of this study was to identify how phosphorylation (via cAMP- and cGMP-dependent protein kinases) / dephosphorylation (via phosphoprotein phosphatase 2A, PP2A) regulates BKCa channel activity in human coronary artery smooth muscle cells (HCASMC). BKCa channel activity was recorded from single HCASMC (Lonza/Clonetics) via single-channel and whole-cell patch-clamp. Channel activity was stimulated by increasing intracellular calcium levels or by increasing either cAMP or cGMP, but the stimulatory effect was mediated predominately via the cGMP-dependent protein kinase. In addition, inhibition of PP2A decreased channel activity. These findings demonstrate that cyclic nucleotide-dependent vasodilators can regulate arterial function via phosphorylation of BKCa channels, and that dephosphorylation of the channel (via PP2A) may  play a role in channel activation. We propose that modulation of BKCa channels via hormone- or drug-induced phosphorylation could be a novel therapeutic means of helping to lower the risk of CVD in both males and females.      
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1. INTRODUCTION 
1.1 Heart Disease 
 Heart disease has long been a major issue plaguing the American population. Data on death rates in the US revealed that a death attributable to cardiovascular disease (CVD) occurs every forty seconds (1). This issue is not confined to the US as CVD is the leading cause of mortality worldwide. Statistical analyses of World Health Organization (WHO) and United Nations data show increased CVD mortality rates in low and middle-income countries in comparison with high-income countries (2). The establishment of low-to high-income countries comes from the World Bank’s use of gross national income per capita to classify countries (3).  The US is considered a high-income nation and follows the trend of declining mortality caused by CVD. However, this does not erase the need for further improvements in curtailing this disease, as it still remains the number one cause of death in America (2).  
 CVD encompasses a multitude of pathophysiological complications obstructing normal activity of blood distribution throughout the cardiovascular system.  Symptoms such as compromised heart and peripheral vessel function impact all body systems and include, but are not limited to heart attacks, ischemic strokes, arrhythmia, and valvular complications (4).  Atherosclerosis and hypertension are two common precursors to CVD that cause restriction of blood flow (5). Atherosclerosis is the build-up of fat, calcium, and cholesterol to form plaque in vessels (6). Plaque occludes blood flow by protruding into the 
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vessel lumen as it grows or by pieces of it breaking off into the lumen (7). Hypertension is a condition in which a person’s blood pressure remains above the accepted value of 139 mmHg systolic and 89 mmHg diastolic. It is important to note that this accepted value for blood pressure is not definitive for each person. However, the more one deviates from this value into higher readings, the more cardiac events are likely to occur (8). According to the American Heart Association statistical studies, one in three adults above the age of twenty are living with hypertension. This shows that this condition is still fairly prevalent even in a society with a declining mortality rate of deaths attributable to CVD (1). 
1.2 Hormones and Heart Disease 
 The impact of sex hormones on vascular health has been widely accepted, however, their exact effect on the cardiovascular system is still debatable due to a wide array of experimental results.  The Fogelberg et al. (9) study showed that inhibition of testosterone aromatization into estrogen promoted atherosclerosis. Another study performed in orchidectimized mice revealed similar findings of inhibition of aromatization yielding plaque formation. These findings support estradiol attenuation of atherosclerotic conditions (10).  Observational studies have also shown that low levels of bioavailable testosterone correlate with lower aortic atherosclerotic manifestation in men >55 years (11). Sex hormones also affect vascular tonicity according to experimental data.  Estrogen is thought to lower hypertension by inducing relaxation of vascular smooth muscle in arteries 
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(12). The growing body of data led many to believe that the introduction of sex hormones could yield positive results against CVD.  
 Negative effects of sex hormones are demonstrated with the use of hormone replacement therapy (HRT) to supplement low estrogen levels during menopause. Women have a lower risk for CVD than men prior to menopausal age.  This decline in advantage after menopause can be attributed to the diminished level of estrogen production in women after this point (13). Women who experience menopause at an earlier age are also more likely to suffer from an ischemic stroke. This implies that the sooner the onset of estrogen decline, the more likely the woman is to develop CVD (14). This along with other data signifying positive effects of hormones led many to believe that the use of HRT to raise estrogen levels would help combat CVD. However, when HRT was introduced in post-menopausal women, their risk for CVD actually worsened. For example, the Women’s Health Initiative clinical trial employed 16,608 postmenopausal women who were given conjugated equine estrogens showed that the incidence of CVD increased in comparison to the placebo group. In fact, the study was cut short due to the strong evidence that estrogen exposure caused pathologies such as CVD and cancer (15). Sex hormones play a major factor in cardiovascular health, and must be used within the correct parameters to be an effective preventative measure for CVD.  
 Whether sex hormones affect vessels is no longer questioned, but their mode of action requires more elucidation. Research is now investigating the 
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exact mechanisms and pathways resulting from sex hormone initiation.  Numerous studies have shown that the introduction of estrogen above “physiologic levels” causes vasodilation of vascular smooth muscle (VSM) cells. In contrast, other studies have shown that estrogen might possibly lead to vasoconstriction in older women (16) Like estrogen, testosterone is a vasodilatory hormone (17).  The discovery of the effects of sex hormones on vascular tone and pressure has shed light on a possible complex pathway where sex hormones could induce vasodilation via a powerful molecular effector protein, the large-conductance, calcium- and voltage-activated potassium (BKCa) channel. The purpose of this study will be to investigate molecular signaling 
mechanisms whereby sex hormones could produce vasodilation by 
opening BKCa channels.   
1.3 Hormones and Receptors 
 The suggested pathways by which sex hormones influence vascular tone are being established by a growing body of research. Most have singled out the production of nitric oxide as a major contributing factor to vasodilation, but sex hormones must prompt a series of biochemical signals before this happens (18). First, estrogen and testosterone bind to their respective receptors on the VSM cell.  Estrogen can bind to at least two types of estrogen receptors (ER), ERα or ERβ. In addition, a novel G-protein-coupled ER (GPER) is also expressed in blood vessels. At present, there is only one known type of androgen receptor for testosterone and it has a highly conserved sequence (16, 19).  Androgen and 
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estrogen receptors differ in their primary sequence by approximately 56 percent, but share a similar quaternary structure with both having a ligand-binding domain made of twelve helices. Sex hormone receptors are found on the membrane in VSM cells. They can also be located in the cytoplasm, which allows sex hormones to bind after permeating the cell membrane (19). The diversity in location of receptors points to the diversity of responses sex hormones are able to induce.  
 Estrogen and testosterone are able convert into other steroid derivatives and still elicit the same vasodilatory response. Aromatase is an enzyme present in the VSM that functions to aromatize testosterone into estrogen (20).  This can then stimulate vascular signaling via the estrogen transduction pathway. There has been discussion as to whether the effects of testosterone on vascular tone and vasodilation are actually due to testosterone itself or to an aromatized form.  Confirmation that testosterone, itself, affects vascular tonicity has been provided through the use of dihydrotestosterone (DHT). DHT is synthesized from testosterone via activity of 5a-reductase (21).  DHT is incapable of aromatization, but can also initiate vasodilation (22). This demonstrates that androgen can cause vasodilation without aromatizing into estrogen.  It also shows how sex hormone-induced vasodilation has multiple molecular effectors. 
1.4 Production of Nitric Oxide: The First Messenger 
 The binding of the hormones to the receptors initiates the activity of several proteins that stimulate nitric oxide synthase (NOS) (23). ERs and ARs 
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activate phosphoinositide 3-kinase (PI3) and protein kinase B (Akt), which subsequently stimulate activity of NOS via phosphorylation (16, 20). NOS is a multifunctional enzyme exhibiting both oxygenase and reductase functions (24). Its oxidation of NADPH can be both coupled and uncoupled. A coupled reaction occurs when NOS uses all the electrons from NADPH to form monooxygenated products such as Nω-hydroxy-L-arginine (NOHA) and NO. Uncoupled reactions of NOS fail to use all of the electrons from NADPH and the excess electrons bind to molecular oxygen reactive oxygen species (ROS) such as superoxide (25). Certain isoforms of the enzyme have a greater propensity towards a coupled or uncoupled reaction. NOS-1 or neuronal NOS (n-NOS) is found in vascular smooth muscle cells.  It has the greatest tendency to produce superoxide under uncoupled conditions and nitric oxide under coupled conditions (16). In terms of vasodilation, a coupled condition is favorable because it yields a vasodilatory product, NO.   
 Although nNOS produces both NO and superoxide, its production of NO is important in the vasodilatory pathway as NO is the “first messenger” in the NO/cGMP/PKG sequence in coupled conditions. NO is produced by nNOS when L-arginine is converted into L-citruline and is considered to be an endothelium-derived relaxing factor (EDRF) (26, 27).  The function of an EDRF is to maintain tone and resistance in vessels (27).   It also activates a series of cascade phosphorylation steps that amplify the reactions of each enzyme involved (28).  The ability of NO to influence vasodilation is largely dependent on its concentration. A varying basal concentration level of NO is constitutively 
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produced depending on the cell type. Changes in cell function occur when rapid increases or decreases in NO concentration deviate from the baseline level (24).  A vasodilatory response occurs when the concentration of NO rapidly surpasses basal levels.  
1.5. BKCa Channels and Hypertension 
 More specifically, the changes occurring in VSM cells are also due to the NO/cGMP/PKG pathway causing increased large conductance calcium-activated K+ (BKCa) channel activity and hyperpolarization (29). BKCa channels are found in all cell types and at greater expression in VSM. A main regulatory mechanism for these channels occurs by phosphorylation or depolarization (30). Depolarization and calcium influx into the cell promotes BKCa channel openings. These openings allow for an efflux of K+ ions and a resulting hyperpolarization of the cell (31). Hyperpolarization inhibits the cell from a stimulatory depolarization and lowers the concentration of cytosolic calcium levels. The decreased concentration of cytosolic calcium results in reduced VSM contraction (29). This series of reactions creates a standard negative-feedback loop. A muscle cell is stimulated by an increase in calcium concentration, and this increased calcium concentration activates BKCa channels which in turn cause a reverse response of vasodilation.  This classic example of negative feedback is important because it is the body’s aim to protect itself from a hypertensive state in vessels. 
 The use of electrophysiological methods has elucidated many of the understood roles of BKCa channels (32-34). Voltage-clamp and patch-clamp 
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experiments using VSM cells to determine current flow through the membrane have revealed a relationship between membrane potential (Em) and vascular tone. An experiment comparing hypertensive animals to normotensive animals found that BKCa current was increased in hypertensive animals (35). The implication of this is that the increased current signified a hyperpolarized membrane and increased activity of BKCa channels. Another study validated the increased activity of BKCa by calculating higher levels of open channel probability (NPo) in hypertensive animals (36).  This use of electrophysiology has revealed that the increase of BKCa channels protects vessels from increased pressure/tension in a normotensive individual. It also serves as an indicator that an individual may be hypertensive if the activity is abnormally high. While it is a seemingly positive protective cellular function, increased level of BKCa channel activity over extended periods of time serve as an indicator of an individual suffering with hypertension or CVD (35). 
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Figure 1: Gonadal steroids open up BKCa channels in coronary artery 
smooth muscle cells (CASMC).  Channel activity before (control) and 10 min after exposure to 100 nM 17β-estradiol (A) or testosterone (B).  Openings are upward deflections from baseline (dashed line), +40 mV.  
 
 
 
 
 
 
 
 
10pA 
500ms 
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1.6 cGMP/cAMP Act As Second Messengers  
  NO production leads to enhanced cGMP synthesis in the VSM.  NO-guanylyl cylcase acts as a catalyst in cGMP’s production from GTP(24). Both cGMP and cAMP amplify the signal causing dilation of vessels. Cascading pathways using cGMP and cAMP signaling molecules increase the openings of BKCa channels and cause dilation (37). Experiments inhibiting NO, but not cGMP, showed that hyperpolarization still occurred in the cell (38). This isolates the importance of  cGMP/cAMP on vasodilation independent of their precursors.  
 The direct influence of cGMP and cAMP on VSM still requires clarification because studies have revealed that they may activate multiple signaling pathways. cGMP and cAMP act as substrates for PKG and PKA,  respectively. They typically elicit antagonistic responses in cells. These cyclic nucleotides have the capacity for cross-activation (PKA by cGMP and PKG by cAMP)(39). Cross-activation allows cAMP to play a role in the NO/cGMP/PKG pathway if cAMP cross-activates PKG. This leaves room for further study of a possible cAMP to PKG pathway and the resulting implications of such as well.  
 Establishing an accurate model for mechanisms by which the cyclic nucleotides interact with the each other and kinases could serve as the key to understanding the NO/cGMP/PKG pathway in the VSM. Cyclic nucleotides indirectly affect the concentration of each other by way of phosphodiesterase (PDE). cAMP increases the level of cGMP indirectly by inhibiting the PDE activity that hydrolyzes the molecule (37).  Inhibiting PDE means an increased amount of 
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cGMP able to interact in the NO/cGMP/PKG pathway. cAMP concentration usually exceeds cGMP by marked amounts at basal levels in all cell types. However, PKG's strong affinity for cGMP offsets this disproportion to favor cGMP binding (24). The use of cross-activation becomes even more important in this regard, because high basal levels of cAMP add to the likelihood that cAMP cross-activates PKG.  
 Data has also shown that estrogen increases accumulation of cAMP in mouse granulosa cells or human coronary artery smooth muscle (40, 41). This shows a direct linkage of sex hormones to second messengers. Further, testosterone increases cGMP levels in coronary arteries and stimulates the activity of either PKG or PKA in these same vessels, although the effect on PKG was predominant (17). In addition, inhibition of PKG activity in coronary artery smooth muscle attenuates vasodilatory signaling mechanisms stimulated by either estrogen or testosterone(17, 42). Thus, these studies reveal a direct linkage of these cyclic nucleotides and their respective kinases to sex hormones and the possible role they play in this vasodilatory pathway.  The increasing research in this area is showing that there are many ways in which this mechanism is carried out.   
1.7 The role of PKA and PKG 
 The direct effect of activating or deactivating PKA or PKG is still uncertain. It has been shown that regulatory binding sites on both PKA and PKG are structurally similar making cross-activation possible due to similar consensus 
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sequences (43).  Even upon this conclusion, there has been some difficulty in determining all of the specific substrates for these kinases because certain substrates are only phosphorylated in vivo or in vitro and not in both experimental conditions (39). There is also evidence showing that some PKG substrates phosphorylated in vivo are actually phosphorylated in vitro as PKA substrates and vice versa (44). 
 With much speculation still remaining on the exact pathway of VSM dilation, a focus should be placed on the role of PKA. The role of PKA in mediating relaxation of VSM is still controversial. Studies have shown that PKA promotes VSM hyperpolarization as a result of increased β-adrenoreceptors and adenylyl cyclase activity(45). Other experiments suggest that BKCa channels are not substrates for PKA phosphorylation, as BKCa channel activity appeared unaffected by PKA inhibition (37, 46). Another theory suggests a mechanism in which PKA phosphorylation subsequently leads to BKCa channel activation (47, 48).  It is evident that the role of PKA is far from being understood. The use of phosphorylation and dephosphorylation to regulate BKCa channels necessitates the understanding of how these kinases modulate channel activity.  
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Figure 2: Proposed mechanism of kinase/phosphatase regulation of BKCa 
channels- Binding of sex hormones to receptors elicits a cascade-signaling pathway with diverse components. Activation of NOS produces the first messenger, NO, and subsequent second messenger cGMP. Cyclic AMP may also be produced from adenylyl cyclase. Channels may be phosphorylated by PKA or PKG, and dephosphorylated by PP2A.  
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1.8 PP2A Mediates PKA Influence 
 As a number of studies have demonstrated that phosphorylation regulates BKCa channel activity, we hypothesize that PKA not only plays a role in BKCa channel activity, but that it may do so indirectly through protein phosphatase 2A (PP2A). PP2A is found ubiquitously in all cells (49). It is a serine/threonine phosphatase that has a regulatory site for phosphorylation and methylation. PP2A is a holoenzyme existing as a heterotrimer. This heterotrimer is composed of a scaffold, catalytic (C), and regulatory (B) subunit (50). More specifically, the B56δ regulatory subunit of PP2A has been phosphorylated by PKA in prior in vitro studies (51) validating a possible relationship between the two in the sex hormone cascade pathway.   
Prior research has suggested that inhibition of PP2A leads to increased BKCa channel activity in mesangial cells (52), thus indicating PP2A as an overall inhibitory phosphatase. Nonetheless, the role of PP2A in regulating BKCa channel activity remains controversial, as other studies have suggested that PP2A activity may open BKCa channels (53, 54). We propose that PP2A dephosphorylates a stimulatory Pi that the BKCa channel has from PKG phosphorylation, leading to channel inactivation (48).   It is possible that PKA activates PP2A by phosphorylation, and an activated PP2A removes a stimulatory Pi  that PKG placed on the BKCa channel. With research on the specific role of PP2A and other intermediates in the mechanism growing yearly, the specific pathway that sex hormones have in influencing vessel dilation will 
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continue to be elucidated. This will ultimately yield more possibilities for effective drug targeting on specific proteins in this extensive signaling pathway.  
1.9 Aims and Hypotheses  
Aim # 1: BKCa channels are only one amongst the three types of voltage-sensitive calcium-activated potassium channels. Therefore, BKCa channel activity must be distinguished from that of the small-conductance calcium-activated potassium channels (SKCa) and the intermediate-conductance calcium-activated potassium channels (IKCa).  
Hypothesis 1: If all three calcium-activated potassium channels are present, the primary channel stimulated by cAMP in HCASMC will be the large-amplitude BKCa channel with a single-channel conductance of approximately 150 pS(55, 56).  
Approach #1:  
1. Run Symmetrical and Physiological I/V Curve 
Current –Voltage (I-V) relationship curves have been used to determine the conductance of the channels found in the patch clamp methods (57). Establishing that the channel inside the patch has a conductance of at least 150 pS will verify that any further experimentation is conducted with BKCa channels and not IKCa and SKCa channels that exhibit lower conductivity.  
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Aim #2: Evidence suggests cAMP-dependent vasodilators increase BKCa channel activity. The proposed experiments will employ the patch-clamp to establish whether or not cAMP-dependent vasodilators activate BKCa channels.  
Hypothesis #2: The use of cAMP-dependent vasodilators above basal concentrations will cause an increase in BKCa channel openings.  
 Previous studies have suggested that forskolin activates the cAMP signaling pathway, leading to an increase in BKCa channel activity. The suggested mechanism is that cAMP cross-activates PKG, leading to BKCa activity increase(37). It is hypothesized that addition of cAMP vasodilators will increase BKCa channel activity. 
Approach #2 
1. Measuring the effect of cAMP-dependent vasodilators on VSM cells 
Studies have shown that forskolin can increase cAMP concentrations by 6-fold in coronary arteries(37).  In this proposed experiment. forskolin will be introduced into the cell suspension chamber to establish whether or not cAMP vasodilators can elicit an effect on BKCa channel activity. 
2. Patch Clamp 
  BKCa channel activity will be recorded before and after addition of cAMP-dependent vasodilators via the patch clamp, and mean channel activity will be determined. This will be calculated by recording the product of the number of channels and the probability that these channels are open (NPo) (# of channels x 
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open probability).  It is anticipated that elevation of cAMP will increase BKCa channel NPo. 
 
Aim #3: Evidence has shown that cAMP works through the NO/cGMP/PKG pathway through cross-activation(58). Is there a mechanism by which cAMP activates PKA and causes some effect on BKCa channel activity? If PKA is not an agonist, is its function on BKCa channels inhibitory of activity or independent?   
Hypothesis #3: cAMP does activate PKA similarly to their activation of PKG and will elicit a response in BKCa channels. 
 Measuring the response of the BKCa channels when only acted upon by PKA will provide a clear model for the exact effect PKA has on the BKCa channels. It is widely accepted that cAMP binds to the regulatory unit of PKA and induces a cascading effect from the resulting phosphorylation from PKA. However, the role that PKA has on BKCa channels is still controversial. The forerunning theory is that PKG acts to open BKCa channels (59). Due to the fact that PKG can be activated by cAMP and cGMP and induce an effect on BKCa channel activity, it is proposed that PKA will also affect activity as well. The evidence showing that only PKG elicits an agonistic response in BKCa channels leaves room for speculation on the purpose of PKA. PKA could serve a directly inverse function in BKCa channel activity by actually deactivating the channel. 
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1. Patch Clamp (Cell-Attached) 
The effect of cAMP-dependent vasodilators (forskolin, or CPT-cAMP) on BKCa channel activity will be measured in intact (cell-attached) patches on coronary artery smooth muscle cells before and after pharmacological inhibition of PKA activity.  
 
Aim #4: If PKA attenuates BKCa channel activity, does this occur indirectly through action on PP2A? 
Hypothesis #4:  PKA’s inhibitory effect on BKCa channels occurs indirectly by its phosphorylation of PP2A and a subsequent dephosphorylation of the BKCa channels leading to inactivation.  
 Studies have shown that PKA does not open BKCa channels(37). Other studies have shown that PP2A functions to inhibit BKCa channels by dephosphorylation (52). PP2A may be the missing link connecting PKA to BKCa channels. PKA could act as a regulator of PP2A. PP2A would then function as a direct regulator of BKCa channels activity.  The fact that the B56δ regulatory subunit of PP2A has been phosphorylated by PKA in prior in vitro studies (51) validates a possible relationship between the two in the sex hormone cascade pathway.   
Approach #4: 
1. Inhibition of PKG and Stimulation of cAMP 
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PKG will be inactivated by KT5823 to ensure that all BKCa channel activity is solely based on PKA 3. Forskolin will also be used to stimulate the production of cAMP. Since, PKG will be inhibited, all activity due to the presence of cAMP will be due to PKA and not PKG.  
2. Inhibition of PP2A 
Pharmacological inhibition of PP2A can be achieved in intact cells by using either okadaic acid or calyculin A. 
3. Patch Clamp    
Channel activity will be measured in cell-attached patches before and after PP2A inhibition. These findings will directly demonstrate either a positive or negative influence of PP2A on BKCa channel activity.  
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2. EXPERIMENTAL DESIGN 
The purpose of this study was to elucidate a possible mechanism in which PKA interacted with BKCa channels. cAMP was first experimentally validated in influencing BKCa channel activity. Data had already shown cAMP acted as a known vasodilator and had stimulatory effects on BKCa channel activity (60). Other prior experimentation had shown that BKCa channel activity might work independently from PKA. Even if the channels were responsive to PKA activity, we had to ensure that PKA was sensitive to cAMP in our model first (37).  BKCa channel activity was recorded by using voltage/patch clamp technique before and after addition of 10 μmol/L forskolin. Forskolin increases the accumulation of cAMP in the cell and  increases activity (37).  Recording activity before and after introduction of forskolin ensured that BKCa channels were responsive and more importantly; responsive to cAMP increase.  
 Evidence had shown that cAMP works through the NO/cGMP/PKG pathway through cross-activation. After establishing that cAMP does alter BKCa channel activity, cAMP’s use of PKA to alter activity had to be singled out separately from NO/cGMP(cAMP)/PKG pathway.   Is there a mechanism by which cAMP activates PKA and causes some effect on BKCa channel activity? 
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3. MATERIALS AND METHODOLOGY 
3.1 Cell Culture Methods  
 Human vascular smooth muscle cells were obtained from Lonza/Clonetics.  Gelatin was poured into 25 cm2 cell culture flasks and 35mm cell culture dishes to cover the bottom surface. Each cell culture dish contained four 12 mm glass cover slips. Gelatin was left in the flasks and dishes for 30 min to allow it to solidify on the bottom. After 30 minutes, excess gelatin liquid was removed. A flask containing cells from the generation being split contained media. Media was decanted off, and cells were washed with 2.5 mL Dulbecco’s Phosphate Buffer Saline (DPBS (1X)). The DPBS (1X) was decanted off and 1 mL of 0.25% Trypsin-EDTA (1X) was added and placed in the incubator for 2 min. After the incubation, cells were viewed under the microscope to ensure they had been freed from the flask’s gelatinous bottom. Media was added to the solution containing cells and trypsin. The quantity of media added depended on the number of flasks and dishes receiving split cells. The total was found by adding 4 mL per flask and 1.5 mL per dish being generated. The solution containing cells, trypsin, and media was triturated to ensure a uniform concentration. This solution was split into the flasks and dishes.  Each flask received 4.5 mL of split cells and each dish received 1.5 mL of split cells. Each flask of original cells was split into three new flasks for the next generation or two new flasks and three 35 mm cell culture dishes containing the cover slips.  Cells were stored in an incubator at 37 ° C  and 5% CO2.  
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3.2 Thawing of Frozen Cultured Cells 
 HCASMC were frozen in liquid nitrogen for use at later dates in experimentation. Upon need, cells were removed from liquid nitrogen and placed in a water bath at 37 ° C  for 2 minutes. 3 mL of media was added to vials containing 1.5 mL of cells and centrifuged for 5 min at 100 rpm.  The supernatant was pipetted off and an additional 4 mL of media was added. This solution containing cells and media was placed in a 25 cm2 cell culture flask already pre-coated with a 2% gelatin solution. 
3.3 Primary Cell Isolation  
 Aortic tissue was excised from male Sprague-Dawley rats in order to harvest VSM cells. The tissue was placed in HEPES solution and stripped of its adventitial layer of cells under a dissecting microscope. The tissue was cut into fragments approximately 1 mm in size and placed in a high K+ solution containing 140 mmol KCl, 10 mmol MgCl2, .01 mmol CaCl2, 10 mmol HEPES, and 30 mmol glucose. An enzymatic reaction to breakdown the media was created with the addition of 6 mg papain, 4 mg dithiothreitol (DTT), and 10 mg albumin dissolved into 5 mL DM solution. Excess high K+ solution was pipetted off the cells and the cells were added to the DM solution. The cellular DM solution was placed on a shaker at 70 rpm for 30 min to physically stimulate the enzymatic reactions. The cellular solution was then removed and triturated. Next, the solution was placed in a 15 mL centrifuge tube and spun in the centrifuge for 10 min at 1000 rpm. Cells in the solution formed a pellet at the bottom of the 
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centrifuge tube. Two or three drops of cellular solution were placed on microscope for electrophysiological patch clamping experiments. Remaining cellular solution was stored at 4oC and kept up to 24 hrs.  
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3.4 Patch Clamp Apparatus 
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A. 
FIGURE 3: Patch Clamp Apparatus- The patch clamp microscope received voltage input from the amplifier via the microelectrode in a closed circuit system. This signal fed back to the A/D converter that converted the analog channel activity into a digital signal that the computer program could interpret. The microelectrode manipulator was used to position the microelectrode in proximity to the cells for patching. The oscilloscope was used to observe the generation of a seal before patching.  
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FIGURE 4: Cell Suspension Chamber- The microelectrode was positioned close to the cell inside of the cell suspension chamber using the microelectrode manipulator. The microelectrode contained a metal wire to allow conduction from the amplifier to the patch located inside its tip. 
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Figure 5: Generating a Mega-Ohm Seal- Microelectrodes were polished to have a 2-5 MΩ resistance prior to forming a giga-ohm seal. The figure shows a 
pipette with a calculated 2 MΩ resistance. As shown, the pipette has not formed a giga-ohm seal, therefore current is still flowing at a recordable value.  
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Figure 6: Seal Formation- A giga-ohm seal has been formed. The high level of resistance formed in the seal prevents current flow and is shown by a horizontal line on the oscilloscope.  
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3.5a  Generating a Giga-Ohm Seal 
 Microelectrodes were generated by pulling 1.50 mm capillary glass tubes with the Sutter Instrument P-2000 microelectrode puller and polished by heat. A polished pipette was determined by having a 2-5 MΩ resistance calculated from the TDS 2002 Two-Channel Digital Storage Oscilloscope recording. Microelectrodes were filled with pipette solution and attached to the MP Sutter Instruments-285micro manipulator. The pipette solution varied depending on experimental conditions. In single channel-cell attached/inside-out conditions, the microelectrode was filled with a normal Ringer solution. In whole cell conditions, the microelectrode was filled with high K+ solution.  The microelectrode was lowered into the recording chamber filled with cellular suspension using the micromanipulator. Once the microelectrode was in positioned in close proximity to the desired cell, suction was applied by mouth through a 1 mL syringe. To determine that a giga-ohm seal had been established, the AxoPatch 200B amplifier from Axon Instruments was set to ‘seal test’ and the oscilloscope reading showed a maximum resistance and no current flow. The prevention of current flow due to high resistance was represented by a horizontal line on the oscilloscope, and verified that a giga-ohm seal had been established. 
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(A) Under single-channel cell-attached conditions, the pipette was filled with Ringer solution containing 5mM of K+ in the form of KCl in order to ensure recording of physiologic cellular conditions for the flow of ions between the pipette and a single channel. (B) Under single-channel inside-out conditions, the pipette was dislodged from the rest of the cell with the seal still intact to a portion of the membrane. The current flow of ions was recorded solely between the channel in the patch and the High K+ bath in the recording chamber. (C) Whole cell recording occurred by rupturing the membrane inside of the patch while the rest of the cell was still attached. The flow of ions through the all channels outside of the patch was recorded.  To ensure that physiologic conditions occurred here, Ringer pipette solution was added to the bath in the recording chamber. 
High K=  
140 K+ 
BATH 
FIGURE 7: Patch Clamp Configurations 
A. B. C. 
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3.5b Single-Channel Cell-Attached  For cell-attached patches, a few drops of cell suspension were placed in the recording chamber.  Several drops of high K+ solution were added to the cell suspension in the recording chamber as well. The microelectrode was filled with Ringer pipette solution and placed on the micromanipulator. Once a giga-ohm seal had been achieved, the ‘seal test’ parameters were removed. With the use of a high K+ bath in the recording chamber, the voltage across the patch was clamped at 0 mV. Currents were filtered at 2kHz and digitized at 10 kHz. Control and experimental groups were clamped at both 0 mV and 40 mV. Addition of forskolin, KT 5720, forskolin + KT 5720,  okadaic acid, okadaic acid + KT 5720, chlorophenylthio-cAMP (CPT-cAMP), CPT-cAMP + KT 5720, sodium nitroprusside (SNP) or tetraethylammonimum (TEA) composed the experimental groups. The drugs were administered to the cell bath after a control recording of the channels was recorded at 0mV and 40 mV. After 10 minutes in the bath, the patch was clamped at 40 mV and activity was recorded. Administration of the second drug occurred after the recording of the first drug. Recording of the subsequent response of the second drug occurred after 10 min.  
3.5c Single Channel Inside-Out 
 A few drops of cell suspension were placed in the recording chamber.  Several drops of high K+ solution were then added to the cell suspension in the recording chamber. The microelectrode was filled with Ringer pipette solution and placed on the micromanipulator. Once a giga-ohm seal had been achieved, 
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the ‘seal test’ parameters were removed. With the cell still attached to the microelectrode, the micromanipulator was used to raise the microelectrode out of the bath and immediately lowered back into the bath. The membrane still maintained a giga-ohm seal with the microelectrode, but the rest of the cell was now detached from the microelectrode. With the use of high K+ bath in the recording chamber, the voltage across the patch was clamped at 0 mV. Currents were filtered at 2kHz and digitized at 10 kHz. Control and experimental groups were clamped at both 0 mV and 40 mV. In the case of the TEA experimental groups, the recordings occurred directly after drug administration.  
3.5d Whole- Cell 
 A few drops of cell suspension were placed in the recording chamber. Several drops of normal Ringer solution were added to the cell suspension in the recording chamber as well. The microelectrode was filled with a high K+ solution with added amphotericin-B  and placed on the micromanipulator. Once a giga-ohm cell was produced, perforations in the cell membrane were produced from  
amphotericin-B and visualized on the oscilloscope. After perforations were generated, the ‘seal test’ parameters were removed. Currents were filtered at 2kHz and digitized at 10 kHz. Control and experimental groups were clamped at and recorded at voltage ranging from -50 mV to 40 mV in 10 mV increments. 
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3.6 Measurement BKCa Channel Activity 
BKCa channel activity was quantified by calculation of the mean open channel probability (NPo).  The NPo values were generated by Clampfit 9.2 and Origin 2.0 computer software. The recordings of BKCa channel activity clamped at a range of voltages in 10 mV increments were also analyzed in Clampfit 9.2 to access the current amplitudes. The current amplitudes were then plotted in Microsoft Excel to calculate the current-voltage (I-V) curves tested in a physiological K+ ionic condition. 
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Patch Clamp Solutions Table   
Solution mM / L Dissociation Medium (DM) 110 NaCl 5 KCl 10 HEPES 10 NHCO3 0.5 KH2PO4 10 Glucose 2 MgCl2 0.16 CaCl2  High Potassium Bath (High K+) 140 KCl 10 MgCl2 0.1 CaCl2 10 HEPES 30 Glucose Normal Ringer  140 NaCl 5 KCl 1 MgCl2 2 CaCl2 10 HEPES   
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4. RESULTS 
4.1 Forskolin Increases Whole-Cell Current in HCASMC 
Whole-cell patch-clamp recording was used to determine the effect of cAMP-dependent vasodilators on HCASMC. Recordings were obtained at 10 mV intervals in a range from -50 mV to +40 mV (Figure 8).  Control group activity was recorded before 10 μM forskolin was added to the cell suspension chamber for experimental group recording. Generation of a current- voltage (I-V) relationship curve quantitatively calculated the relationship of outward current to voltage in the cell. As the clamped voltage increased, the current subsequently increased revealing a positive correlation in both the control and experimental groups. The addition of forskolin increased the outward current of the whole cell in the experimental group compared to the control group when clamped at voltages above -20 mV. At voltages under -20 mV, the control group had a greater outward current.  
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FIGURE 8: A cAMP-dependent vasodilator increases 
outward current in HCASMC. Forskolin (10 μM, 10 min) increased outward current in HCASMC. A) Current traces recorded before (red) and 10 min after (blue) addition of forskolin (+40mV). B) Complete current (I)-voltage (V) relationship before (red) and after (blue) forskolin. 
-50     -40      -30       -20        -10        0        10          20        30         40  
                     Membrane Voltage (mV)  
Cu
rr
en
t (
pA
) 
     50 pA 
 
       50 ms 
+40 mV 
-60 mV 
 
 
+40mV 
  
 
36 
 
 
4.2  BKCa Channels are expressed in HCASMC 
 Although cAMP generation increased outward currents, the identification of the channel(s) involved cannot be determined from whole-cell studies. Therefore we identified the specific channel stimulated by cAMP at the molecular level by performing single-channel patch-clamp studies.  Activity in both cell-attached and inside-out patch configurations confirmed the presence of BKCa channels in HCASMC when clamped at +40 mV. Recordings of the patch clamp traces noted distinguishable channel openings and closings (FIGURE 9A, 9B).  Channel openings were observable in physiological concentrations of calcium (10-7 M) where channels were patched in cell-attached configurations. Exposure to higher concentrations of calcium (10-4M) in the high K+ solution showed a 1,000 fold (p< .001; n=3 ) increase in channel activity. This increased exposure was accomplished by detaching the channel in the patch from the rest of the cell so that the channel could now be exposed to the higher concentration of calcium in the cell suspension chamber. The amplitude of the channel openings was approximately 10 pA at +40mV.  
 Channel conductance was calculated to distinguish the presence of of BKCa from IKCa and SKCa channels. The calculated channel conductance was 152.4 ± 7 pS (n= 4 patches) using the slope from an I-V relationship plot. The voltages for this relationship were clamped with the cells being in physiological K+ concentration (FIGURE 9C).  
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 Addition of 1-5 mM of TEA to the cell suspension chamber in an inside-out configuration clamped at 0 mV yielded a 100-fold decrease in BKCa channel activity. The NPO for the control and experimental recordings were 0.9130 and 0.0079, respectively. The patch clamp traces validated the data with an observable decrease in BKCa channel activity after the addition of TEA (10A, 10B).  
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Figure 9: BKCa channel identification in HCASMC. (A) Channel activity recorded in the same HCASMC patch (+40mV). 
Upper trace: cell-attached patch (normal calcium; 10-7 M calcium). 
Lower trace: inside-out patch (100μM calcium). (B) On average, raising calcium increased channel activity by > 1000-fold (bar graph; *p<0.001; n=3). (C) Channel conductance is ~150 pS in physiological [K+] (n=4 patches).  
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FIGURE 10: TEA inhibits BKCa channel activity in inside-out patch. (A) 
Left trace: High level of BKCa channel activity with distinguishable openings and closings (0 mV). Right Trace: Decreased level of BKCa channel activity after addition of 10 μM TEA. (B) NPO decreased 100-fold after addition of TEA. (n=1) 
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4.3 Elevating cAMP Increases BKCa Channel Activity in Cell-Attached Patches 
 Increasing the level of cAMP in HCASMC  increased the level of BKCa channel activity. Recordings of cell-attached patches at +40 mV before (control) and 10 min after addition of 10 µM forskolin were collected. The traces showed observable increase with forskolin(FIGURE 11). The NPo of the control and forskolin group were 0.0525 and 0.0778, respectively (FIGURE 12) (n=1).  Recordings after the addition of chlorophenythio-cAMP showed a similar trend. CPT-cAMP is a membrane-permeable derivative of cAMP that can influence channels still attached to the rest of the cell. Addition of either cAMP-stimulating drugs caused an NPo of 0.0689, while the control NPo was 0.0523 (FIGURE 12). The trace comparing channel activity before (control) and 30 min after the addition of 100µM CPT-cAMP showed an even more distinguishable difference in channel activity than when the control was compared to forskolin. This data suggests a positive correlation between stimulation of cAMP and BKCa channel activity. 
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10pA 
500ms 
FIGURE 11: cAMP-dependent vasodilators increase BKCa 
activity in HCASMC. Upper traces: Recordings from a cell-attached patch (+40mV) before and 10 min after addition of 10mM forskolin. Lower traces:  Recordings from another cell-attached patch (+40mV) before and 30 min after addition of 100mM chlorophenylthio (CPT)-cAMP, a membrane-permeable derivative.Channel openings are upward deflections from baseline.  
Effect of cAMP on BKCa Channel Activity 
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FIGURE 12: Addition of Forskolin Increases BKCa Channel Activity.  Calculations of NPo from cells patched before (control) and 10 min after addition of 10 μM forskolin. Additions of forskolin increased NPo from 0.0525 to 0.0778 
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4.4  BKCa Channel Activation is Mediated Via PKG, But Independent of PKA 
 BKCa activity increased using 10 μM forskolin in cell-attached patches. Forskolin increased activity, so that any possible inhibition of activity would be observable on the trace.  A trace was recorded 10 min after forskolin was added followed by the addition of the  PKA inhibitor (300 nM KT 5720). The trace of the control showed observable channel openings for what appeared to be one channel present in the patch (FIGURE 13A). Forskolin addition increased the channel openings in the trace to a distinguishable level of second channel openings  approximately 20 pA above baseline. The subsequent addition of KT 5720 showed no observable increase in channel activity from that of the forskolin addition suggesting BKCa channels may not be a target of PKA activity. The NPO values for the control, forskolin addition, and subsequent KT 5720 addition were 0.0523,  0.0689, and 0.0675, respectively (FIGURE 14A). This validated the trace showing an increase in channel activity with the addition, but no change after the addition of KT 5720. 
   Comparing the traces before (control) and 10 min after the addition of a PKG stimulator sodium nitroprusside (SNP), an NO donor, showed an observable increase in BKCa channel activity suggesting that channel activity increases with activation of PKG. Stimulation of PKG activity with SNP showed an increase from control activity with NPO values increasing from 0.0102 to 0.1310.  Activation of PKG increased BKCa channel activity 10-fold (FIGURE 14B).  
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Figure 13: Inhibition of PKA does not affect BKCa channel activity, but 
activation of PKG opens channels.  (A) Channel activity recorded in the same HCASMC patch (+40mV) before (control), 10 min after 10 μM forskolin, and 20 min after addition of 300nM KT5720 (PKA inhibitor).  Inhibition  of PKA did not affect channel activity. (B) Channel activity recorded in the same HCASMC patch (+40mV) before (control) and 12 min after 10 μM sodium nitroprusside (SNP; PKG activator). 
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4.5 Inhibiting Channel Dephosphorylation Decreases BKCa Channel Activity 
A 
B 
FIGURE 14:  BKCa Channel Activity increased with PKG 
activity and is independent of PKA activity. (A) After stimulating control activity with 10 μM forskolin, inhibition of PKA with KT 5720 showed now change in channel activity. (B) Stimulating PKG with 10 μM SNP increased channel activity 10 fold. 
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 Patch-clamp traces using cell-attached methods validated that BKCa channel activity was stimulated with the addition of 100 µM CPT-cAMP for 30 min when clamped at +40 mV. Addition of CPT-cAMP to the control increased the NPO 100-fold from 0.0025 to 0.3176 (FIGURE 15B).  In FIGURE 15A, two levels of BKCa channel activity can be distinguished by the openings at approximately 10 pA and 20 pA amplitudes.  Subsequent addition of PP2A inhibitor (100 nM okadaic acid) for another 15 min showed a definitive decrease in channel activity now with only one channel being activated at an amplitude of approximately 10 pA. The subsequent addition of OA dropped the NPO back down again 50-fold from 0.3176 to 0.0064. The graph showed significant increase in channel activity with CPT-cAMP and decrease with OA (*p<0.05) (n=3).   
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Figure 15: Okadaic acid reverses cAMP-stimulated BKCa 
channel activity in HCASMC.(A) Representative recordings from a cell-attached patch (+40mV) HCASMC treated with 100mM CPT-cAMP (30 min) and 45 min after 100nM okadaic acid (OA). Channel openings are upward deflections from the baseline (closed) state (dashed line).  (B) Summary graph demonstrating significant (*p<0.05) channel stimulation by cAMP with subsequent inhibition by OA (n=3), which is a selective inhibitor for PP2A.    
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5. DISCUSSION 
 The importance of BKCa channels in vasodilation has been confirmed by many studies, however the mechanism behind this important regulatory effector still needs elucidation. It is apparent that after gonadal steriods bind to their receptors there is subsequent activation of PI3, Akt kinases, and nitric oxide synthase (61, 62). Nonetheless, we still do not understand the precise role of the cyclic nucleotide-dependent kinases activated subsequent to cyclic nucleotide generation. Working with the common precept that PKG activates BKCa channels, we constructed a mechanism in which PKG activates the channels via phosphorylation. Prior research shows that PKG and PKA exhibit antagonistic responses, leading to a proposal that PKA phosphorylation inhibited channel activity (39). The belief that PKA phosphorylation works with PP2A dephosphorylation stems from prior data reporting PP2A as a possible substrate for PKA (51) and data showing PP2A inhibition increasing BKCa activity. This evidence supported our initial hypothesis of indirect PKA and direct PP2A inhibition of BKCa via phosphorylation and dephosphorylation.  
 To examine the role of the cyclic nucleotide-dependent kinases on the channels, we first established that BKCa channels were actually expressed in HCASMC. The BKCa channel is known to be depolarization-activated and also calcium-dependent (31). The currents recorded in whole-cell experiments increased with voltage, so it verified a voltage-dependency of the channels in HCASMC. Subsequent experiments on inside-out patches revealed that 
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increasing calcium at the cytoplasmic surface of the channel stimulated activity. Stimulation of cAMP production increased whole-cell outward currents in HCASMC.  Interestingly, however, we noted that cAMP did not appear to increase outward currents at negative (i.e., < -20mV) voltages. This finding could be attributed to the fact that BKCa channels are voltage-dependent and require a depolarized cell to activate. The lower the voltage, the less likely BKCa channels are to be active.  In contrast, as the cell was increasingly depolarized (> -20mV) forskolin had more influence on BKCa activity.  These findings are consistent with a model where BKCa channels carry the majority of outward current in HCASMC, are deplarization-activated, and highly sensitive to stimulation by cAMP. Thus, we propose that cAMP is an important signaling molecule in the signaling cascade governing BKCa channel activity.  
 However, these data alone could not verify that the increase of outward current on the cellular level was solely due to BKCa channel response. To verify this increase was due mainly to calcium-activated channels, we assessed the response of BKCa channels on a molecular level. Single channels in cell-attached patches are functioning at physiological levels of Ca2+ (10-7 M), and this basal level of BKCa activity was recorded. After excising the patch into an inside-out configuration to expose these channels to high Ca2+ concentration (10-4 M), the activity increased 1,000-fold. These findings verified the expression of calcium-activated potassium channels in HCASMC, and further suggested that the original increase in the outward current on the cellular level was due primarily to activity of calcium-activated channels.  
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 Smooth muscle cells also express other calcium-activated K channels:   IKCa and SKCa channels. Establishing that the channels were calcium-sensitive was important, but did not differentiate between the types of these K channels; i.e., BKCa , IKCa and/or SKCa. Generation of a single-channel I-V relationship in physiological potassium gradients allowed us to calculate the conductance of the calcium-activated channel to be an average of 152.4 ± 7 pS. Experimentation has shown that the conductance of BKCa, IKCa, and SKCa channels under these conditions is ~150 pS, ~39 pS, and ~10 pS, respectively. (57).  Our calculated conductance value agreed with the accepted value and validated that the activity observed in the traces was due primarily to BKCa channels.  
 Measuring the open-channel amplitude and exposing an inside-out patch to TEA also confirmed the presence of BKCa channels in HCASMC. The recorded amplitude of the channel openings was approximately 10 pA at +40mV. This was in the characteristic range for BKCa channels found in other studies involving myocytes from both porcine and human tissues when clamped at this voltage (63, 64).  Channels were clamped at +40 mV because prior experimentation from our lab and other studies have shown that BKCa channels are clearly distinguishable at this voltage (37, 65). Lastly, when the channel was exposed to TEA in an inside-out patch, the channel activity decreased 100-fold. TEA is a known BKCa channel blocker with higher selectivity for BKCa channels at lower concentrations, i.e., <1 mM (66). Thus, our experiments have defined that the channel responsible for the majority of outward current in HCASMC is depolarization-activated, highly calcium-dependent, sensitive to inhibition by 
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TEA, and has a large molecular conductance. Therefore, we have identified this protein as the BKCa channel known to be highly expressed in coronary artery smooth muscle cells.  
 We had observed that forskolin increased whole-cell outward currents in HCASMC. However, the cell-attached patch revealed the effect of this cAMP-dependent vasodilator on BKCa channels. The NPO increased after the addition of forskolin, which confirmed BKCa channel sensitivity to cAMP. The NPO increased even greater with the addition of CPT-cAMP. The variation in the BKCa  response between forskolin and CPT-cAMP could be attributed to the fact that forskolin directly activates adenylyl cyclase and indirectly increases cAMP, while CPT-cAMP is a membrane-permeable derivative of cAMP and serves to directly increase the cyclic nucleotide. These experiments clearly demonstrated that increasing intracellular cAMP levels stimulates BKCa channel activity in HCASMC. 
 Testing for the role of cyclic nucleotide-dependent kinases suggested that PKG stimulates BKCa channel activity while PKA activity may not affect channel activity. Addition of a PKG stimulator (SNP) increased NPO 10-fold, while addition of a PKA inhibitor (KT 5720) showed no observable change in activity. The data validated the common belief that PKG stimulates BKCa channels, but still leaves many things to question about the role of PKA. The decreased channel activity following addition of the PP2A inhibitor (okadaic acid) suggests that PP2A may play a stimulatory role rather than inhibitory. The data showed that PKG and PP2A both play a role in activating the channel, and perhaps they do 
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this in conjunction. Instead of PP2A working with PKA to dephosphorylate a stimulatory phosphate off of the channel, PP2A may function following activation by PKG to dephosphorylate an inhibitory phosphate from the channel. In other words, PP2A activity may mediate a more indirect stimulatory effect of PKG on BKCa channel activity, instead of requiring direct PKG-dependent phosphorylation of the channel protein. To our knowledge, this is the first time this mechanism has been demonstrated in coronary arteries (particularly in human coronary artery smooth muscle). However, support for this mechanism is derived from similar studies done in mesenteric microvascular smooth muscle cells (53). Nonetheless, the role of PP2A may be more complicated, as researchers found that PP2A activation  could inhibit BKCa channel activity in mesangial smooth muscle cells (67).  Although these data differ from our original proposed function of PP2A, it now sheds light on possible variability in PP2A function depending on cell type and localization.  
 Our study adds to an increasing effort to identify the signaling pathways regulating BKCa channel activity. The activity of BKCa channels is regulated by their phosphorylation by cyclic nucleotide-dependent kinases and dephosphorylation by protein phosphatases. We concluded that PKG stimulates the channels. Other studies also support this finding. Fukao et al. (1999) reported similar findings as SNP also increased BKCa channel activity in cloned BKCa channels from canine colonic smooth muscle cells (68).  More importantly, the addition of PKG and ATP to the cytosolic surface of BKCa channels increased the NPo 3.2-fold in cloned colonic smooth muscle cells (37, 69). Another study 
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found that BKCa channels have a strong consensus site for PKG phosphorylation near the COOH terminal end. The channels also have 11 possible sites for PKA phosphorylation, however, these are all weaker consensus sites (70). The presence of a PKG consensus site in this study confirms that the BKCa channel is a likely substrate for PKG-dependent phosphorylation. The evidence of weak consensus PKA phosphorylation sites gives cause to further investigate its role as our data suggests that channels are actually unaffected by PKA activity. The role of PP2A also needs further investigation. Imig et al. (54) inhibited PP2A in renal artery smooth muscle cells and observed decreased BKCa channel activity. This was congruent to results from our experiments in coronary artery smooth muscle cells.  Further, White et al.  (46) reported that okadaic acid inhibited cGMP-stimulated BKCa channel activity in neuroendocrine cells.  Thus, there is evidence from both vascular and non-vascular cells that PP2A mediates a stimulatory effect on BKCa channels. In contrast, other studies report an inhibitory role for PP2A. For example,  Sansom et al.  (1997) reported that the inhibition of PP2A increased BKCa channel activity in mesangial cells (52). Taken together, the contradictory results with  these kinases and phosphatase confirm the need for increased investigation into defining the signaling mechanism whereby phosphorylation / dephosphorylation regulates BKCa channel activity. 
 This study investigated the molecular signaling mechanisms of BKCa channels that mediate coronary artery relaxation. The BKCa channel is a highly-expressed protein in HCASMC, and we found activity of this channel dominates membrane electrical activity in these cells. These channels provide a powerful 
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repolarizing influence that closes voltage-dependent calcium channels, thereby leading to HCASMC relaxation and coronary artery vasodilation. Given the important role played by BKCa channels, integration of our data for potential clinical use is most important. It is critical to determine the exact vasodilatory mechanism involving BKCa channel activation because this will provide strong implications for these mechanisms serving as novel pharmacological targets to relieving myocardial ischemia or hypertension. Hypertension accompanies multiple disease states, such as diabetes, hypoxia, obesity, and CVD (71-73) As these diseases are spread amongst all demographics, finding a drug therapy to target hypertension, one of the major symptoms, could greatly increase the health of an entire population.  
 There is increasing evidence that hypertension-related diseases exhibit alterations in molecular signaling. One study showed that increased levels of phosphorylated-Akt (p-Akt) were linked to pulmonary hypoxia, and that the use of an anti-hypoxic drug, baicalin, increased BKCa channel activity (71).  Research showed that NOS activity was increased in obese rats in comparison to control (74) Another study linked higher BKCa channel NPO and  lower channel conductance to rats with streptozotocin-induced diabetes in their thoracic aortic smooth muscle cells (75).  A wide variety of physiological and disease states are influenced by activity of BKCa channels and their regulatory molecules (e.g., Akt, NOS). Understanding the cascading pathways that determine their function will help clinicians and pharmacuetical companies more effectively target the many diseases that exist due to BKCa channel function and dysfunction.   
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FIGURE 16: Modified BKCa mechanism with stimulatory PP2A. Both PKG and PP2A elicited increased BKCa response. In this modified mechanism, PKG phosphorylates PP2A. This activates PP2A to remove an inhibitory Pi. The source of the Pi still needs to be determined. PKA could be the kinase responsible for the addition of the Pi.  
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6. CONCLUSION AND FURTHER STUDIES 
 In conclusion, these findings are the first to provide evidence suggesting that dephosphorylation by PP2A opens BKCa channels in human coronary artery smooth muscle cells. The data also links gonadal steroids, cyclic nucleotides,  and BKCa channel activity.  We propose PP2A to be an exciting novel therapeutic target to promote coronary artery vasodilation and thereby reduce ischemic injury. Given the increased use of gonadal steroids, particularly in older women and men, it would be of subtantial health benefit to understand how these powerful hormones can modify cardiovascular function. An important goal would be to isolate the signaling mechanisms of gonadal steroids in blood vessels from the endocrine effects of these hormones, thus helping to potentially maximize their therapeutic use while minimizing unwanted or dangerous side effects.  
 Further objectives for this research would call for running more trials to establish the potential clinical significance of the data. I also propose testing for the influence of PP2A working in conjunction with PKG on BKCa channel activity.  He (2000)  showed that PKG may not directly activate channels leading to the belief that there is an intermediate molecule involved in activation (76). Experimentation on whether or not PP2A is actually a substrate for PKG would clearly support their relationship.  Finally determining the level of PP2A in various types smooth muscle tissues would shed light on the why its function has shown varying effects depending on the cell type.   
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